Jarr, K., Luo, L., & Leeper, N. J. (2025). The atherosclerosis-cancer axis: The shared immunotherapeutic potential of CBL inhibition. European heart journal, 46(45), . https://doi.org/10.1093/eurheartj/ehaf624
Chicago Style (17th ed.) CitationJarr, Kai-Uwe, Lingfeng Luo, and Nicholas J. Leeper. "The Atherosclerosis-cancer Axis: The Shared Immunotherapeutic Potential of CBL Inhibition." European Heart Journal 46, no. 45 (2025). https://doi.org/10.1093/eurheartj/ehaf624.
MLA (9th ed.) CitationJarr, Kai-Uwe, et al. "The Atherosclerosis-cancer Axis: The Shared Immunotherapeutic Potential of CBL Inhibition." European Heart Journal, vol. 46, no. 45, 2025, https://doi.org/10.1093/eurheartj/ehaf624.
Warning: These citations may not always be 100% accurate.